Targeting Rac1 signaling to improve outcomes for cancer patients

Revere Pharmaceuticals is an oncology focused biotechnology company leading the development of small molecule therapeutics targeting Rac1 signaling for cancers with unmet clinical need. Rac1 activity is a key driver of metastatic progression and drug resistance in diverse cancer types.